These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30520143)

  • 1. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
    Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
    Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
    Chun J; Li RJ; Cheng MS; Kim YS
    Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway.
    Yang L; Lin S; Kang Y; Xiang Y; Xu L; Li J; Dai X; Liang G; Huang X; Zhao C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):31. PubMed ID: 30674340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB.
    He R; Shi X; Zhou M; Zhao Y; Pan S; Zhao C; Guo X; Wang M; Li X; Qin R
    Toxicol Appl Pharmacol; 2018 Oct; 356():159-171. PubMed ID: 30086361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
    Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
    Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction.
    Khan M; Li T; Ahmad Khan MK; Rasul A; Nawaz F; Sun M; Zheng Y; Ma T
    Biomed Res Int; 2013; 2013():719858. PubMed ID: 23533997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress.
    Maryam A; Mehmood T; Zhang H; Li Y; Khan M; Ma T
    Sci Rep; 2017 Jul; 7(1):6242. PubMed ID: 28740138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth.
    Nagaraj NS; Washington MK; Merchant NB
    Clin Cancer Res; 2011 Feb; 17(3):483-93. PubMed ID: 21266529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alantolactone exhibits antiproliferative and apoptosis-promoting properties in colon cancer model via activation of the MAPK-JNK/c-Jun signaling pathway.
    Ren Y; Lv C; Zhang J; Zhang B; Yue B; Luo X; Yu Z; Wang H; Ren J; Wang Z; Dou W
    Mol Cell Biochem; 2021 Dec; 476(12):4387-4403. PubMed ID: 34460036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition.
    Ioannou N; Seddon AM; Dalgleish A; Mackintosh D; Solca F; Modjtahedi H
    Int J Oncol; 2016 Mar; 48(3):908-18. PubMed ID: 26781210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion.
    Wei W; Huang H; Zhao S; Liu W; Liu CX; Chen L; Li JM; Wu YL; Yan H
    Apoptosis; 2013 Sep; 18(9):1060-70. PubMed ID: 23613107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
    Lu YY; Jing DD; Xu M; Wu K; Wang XP
    World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance.
    Yao Y; Xia D; Bian Y; Sun Y; Zhu F; Pan B; Niu M; Zhao K; Wu Q; Qiao J; Fu C; Li Z; Xu K
    Apoptosis; 2015 Aug; 20(8):1122-33. PubMed ID: 26033479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR inhibition induces EGFR feedback activation in association with its resistance to human pancreatic cancer.
    Wei F; Zhang Y; Geng L; Zhang P; Wang G; Liu Y
    Int J Mol Sci; 2015 Feb; 16(2):3267-82. PubMed ID: 25654224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3.
    Tang J; Guo F; Du Y; Liu X; Qin Q; Liu X; Yin T; Jiang L; Wang Y
    Int J Oncol; 2015 May; 46(5):2083-95. PubMed ID: 25695284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells.
    Chun J; Choi RJ; Khan S; Lee DS; Kim YC; Nam YJ; Lee DU; Kim YS
    Int Immunopharmacol; 2012 Dec; 14(4):375-83. PubMed ID: 22940184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway.
    Wang S; Wang Y; Huang Z; Wei H; Wang X; Shen R; Lan W; Zhong G; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1670-1680. PubMed ID: 34693451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
    Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
    Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alantolactone inhibits cell proliferation by interrupting the interaction between Cripto-1 and activin receptor type II A in activin signaling pathway.
    Shi Y; Bao YL; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
    J Biomol Screen; 2011 Jun; 16(5):525-35. PubMed ID: 21378277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway.
    He W; Cao P; Xia Y; Hong L; Zhang T; Shen X; Zheng P; Shen H; Zhao Y; Zou P
    Free Radic Res; 2019 Jan; 53(1):104-114. PubMed ID: 30668191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.